FMP
Lixte Biotechnology Holdings, Inc.
LIXT
NASDAQ
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.
2.33 USD
-0.055 (-2.37%)
GlobeNewsWire
Aug 15, 2024
-Company to Present August 20 at Investor Summit Summer 2024 Virtual Conference; and September 9-11 at H.C. Wainwright 26 th Annual Global Investment Conference-
Accesswire
Aug 14, 2024
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
PennyStocks
Feb 13, 2023
Here's some tips for sustainably investing in penny stocks The post How to Sustainably Invest in Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace
Feb 8, 2023
Lixte Biotech (NASDAQ: LIXT ) stock is dropping on Wednesday but it's not due to any negative news from the drug discovery company. Instead, it's the result of shares retreating after a massive rally on Wednesday.
PennyStocks
Feb 8, 2023
Are penny stocks able to provide full time income? The post Can Trading Penny Stocks Be a Full Time Job?
Accesswire
Nov 30, 2022
Presentation to be Broadcast Wednesday December 7 at 3:30 p.m. EST/12:30 p.m.
InvestorPlace
May 9, 2022
Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel's top short squeeze candidates.
PennyStocks
May 5, 2022
Are these trending penny stocks on your watchlist in May? The post Trending Penny Stocks to Watch As the First Week of May Ends appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace
May 2, 2022
Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.
Benzinga
May 2, 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.